PubRank

Augusto Amici

Author PubWeight™ 35.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutations. Cancer Res 2009 1.64
2 Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice. Cancer Res 2004 1.38
3 Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. Clin Cancer Res 2005 1.18
4 Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas. J Clin Invest 2003 1.17
5 A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. Cancer Res 2010 1.05
6 p130Cas is an essential transducer element in ErbB2 transformation. FASEB J 2010 1.05
7 Combining human and rat sequences in her-2 DNA vaccines blunts immune tolerance and drives antitumor immunity. Cancer Res 2010 1.05
8 The human splice variant Δ16HER2 induces rapid tumor onset in a reporter transgenic mouse. PLoS One 2011 0.97
9 Transfection efficiency boost by designer multicomponent lipoplexes. Biochim Biophys Acta 2007 0.95
10 LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. Cancer Res 2003 0.94
11 Mesenchymal/stromal gene expression signature relates to basal-like breast cancers, identifies bone metastasis and predicts resistance to therapies. PLoS One 2010 0.92
12 Restricted innervation of uterus and placenta during pregnancy: evidence for a role of the repelling signal Semaphorin 3A. Dev Dyn 2004 0.91
13 Structural stability and increase in size rationalize the efficiency of lipoplexes in serum. Langmuir 2009 0.90
14 Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain. Hum Gene Ther 2008 0.90
15 Low effectiveness of DNA vaccination against HER-2/neu in ageing. Vaccine 2003 0.90
16 Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2. Breast Cancer Res 2014 0.89
17 Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells. Carcinogenesis 2005 0.88
18 The impact of early life permethrin exposure on development of neurodegeneration in adulthood. Exp Gerontol 2011 0.87
19 p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells. Breast Cancer Res 2012 0.86
20 Tumor vessel compression hinders perfusion of ultrasonographic contrast agents. Neoplasia 2005 0.85
21 DNA vaccination against oncoantigens: A promise. Oncoimmunology 2012 0.85
22 Factors determining the superior performance of lipid/DNA/protammine nanoparticles over lipoplexes. J Med Chem 2011 0.84
23 Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. J Immunol 2006 0.84
24 Enhanced transfection efficiency of multicomponent lipoplexes in the regime of optimal membrane charge density. J Phys Chem B 2008 0.83
25 Structural stability against disintegration by anionic lipids rationalizes the efficiency of cationic liposome/DNA complexes. Langmuir 2007 0.83
26 Evaluation of different plasmid DNA delivery systems for immunization against HER2/neu in a transgenic murine model of mammary carcinoma. Vaccine 2005 0.83
27 Early life permethrin exposure induces long-term brain changes in Nurr1, NF-kB and Nrf-2. Brain Res 2013 0.82
28 Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors. Int J Oncol 2007 0.82
29 Immunological prevention of spontaneous tumors: a new prospect? Immunol Lett 2002 0.81
30 Tailoring DNA Vaccines: Designing Strategies Against HER2-Positive Cancers. Front Oncol 2013 0.81
31 Tailoring lipoplex composition to the lipid composition of plasma membrane: a Trojan horse for cell entry? Langmuir 2010 0.81
32 Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans. Cancers (Basel) 2011 0.80
33 In vivo mapping of spontaneous mammary tumors in transgenic mice using MRI and ultrasonography. J Magn Reson Imaging 2004 0.80
34 Toward the rational design of lipid gene vectors: shape coupling between lipoplex and anionic cellular lipids controls the phase evolution of lipoplexes and the efficiency of DNA release. ACS Appl Mater Interfaces 2009 0.78
35 Leukocyte Nurr1 as peripheral biomarker of early-life environmental exposure to permethrin insecticide. Biomarkers 2012 0.77
36 Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD). PLoS One 2013 0.77
37 Walking a Tightrope: A Perspective of Resveratrol Effects on Breast Cancer. Curr Protein Pept Sci 2017 0.77
38 Universality of DNA adsorption behavior on the cationic membranes of nanolipoplexes. J Phys Chem B 2010 0.76
39 Programmed packaging of multicomponent envelope-type nanoparticle system (MENS). J Control Release 2010 0.76
40 Biosafety evidence for human dedifferentiated adipocytes. J Cell Physiol 2015 0.75
41 Surface adsorption of protein corona controls the cell uptake mechanism in efficient cationic liposome/DNA complexes in serum. J Control Release 2010 0.75
42 Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9-11, 2013. Cancer Immunol Immunother 2014 0.75